Osaic Holdings
RLAY icon

Osaic Holdings’s Relay Therapeutics RLAY Stock Holding History

Osaic Holdings’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Sell
149,664
-36,459
-20% -$529K ﹤0.01% 2024
2026
Q1 		$1.85M Sell
186,123
-265
-0.1% -$2.37K ﹤0.01% 2140
2025
Q4 		$1.58M Hold
186,388
– – ﹤0.01% 2288
2025
Q3 		$970K Buy
186,388
+184,475
+9,643% +$703K ﹤0.01% 2825
2025
Q2 		$6.52K Buy
1,913
+112
+6% +$333 ﹤0.01% 6395
2025
Q1 		$4.72K Sell
1,801
-894
-33% -$3.5K ﹤0.01% 6213
2024
Q4 		$11.1K Sell
2,695
-20,939
-89% -$114K ﹤0.01% 5721
2024
Q3 		$167K Buy
23,634
+23,292
+6,811% +$174K ﹤0.01% 3798
2024
Q2 		$2.23K Sell
342
-24,031
-99% -$164K ﹤0.01% 6553
2024
Q1 		$202K Buy
24,373
+142
+0.6% +$1.39K ﹤0.01% 3669
2023
Q4 		$267K Sell
24,231
-46
-0.2% -$388 ﹤0.01% 3689
2023
Q3 		$204K Sell
24,277
-15
-0.1% -$161 ﹤0.01% 3979
2023
Q2 		$305K Sell
24,292
-87
-0.4% -$1.08K ﹤0.01% 3568
2023
Q1 		$402K Buy
24,379
+60
+0.2% +$1.08K ﹤0.01% 3284
2022
Q4 		$364K Sell
24,319
-33
-0.1% -$632 ﹤0.01% 3319
2022
Q3 		$544K Buy
24,352
+149
+0.6% +$3.27K ﹤0.01% 2819
2022
Q2 		$405K Sell
24,203
-24,200
-50% -$519K ﹤0.01% 3141
2022
Q1 		$1.45M Hold
48,403
– – ﹤0.01% 2219
2021
Q4 		$1.49M Hold
48,403
– – ﹤0.01% 2042
2021
Q3 		$1.53M Hold
48,403
– – ﹤0.01% 1962
2021
Q2 		$1.77M Hold
48,403
– – ﹤0.01% 1824
2021
Q1 		$1.67M Buy
+48,403
New +$2.1M ﹤0.01% 1763

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Osaic Holdings's RLAY Position: Q2 2026 in Review

Osaic Holdings reduced its Relay Therapeutics (RLAY) stake by 20% in Q2 2026, selling an estimated $529K and leaving 149,664 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2024.

Osaic Holdings first reported a position in RLAY in Q1 2021 and has held it in 22 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Osaic Holdings held 149,664 shares of Relay Therapeutics worth $2.8M as of Q2 2026.
  • Osaic Holdings sold 36,459 Relay Therapeutics shares in Q2 2026, an estimated $529K.
  • Relay Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2024 holding.
  • Osaic Holdings first reported a position in Relay Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.